QuidelOrtho Corporation is a global in vitro diagnostics company that manufactures and distributes diagnostic testing solutions across five business units—Labs, Molecular Diagnostics, Point of Care, Transfusion Medicine, and contract manufacturing—serving hospitals, clinical laboratories, blood banks, and point-of-care settings in over 140 countries. The company offers a broad portfolio including VITROS clinical chemistry systems, rapid immunoassay instruments (SOFIA platform), lateral-flow tests (QUICKVUE), molecular diagnostics platforms (LYRA and SOLANA), and transfusion medicine analyzers. QuidelOrtho employs a recurring-revenue "razor/razor blade" model, placing diagnostic instruments under long-term contracts while generating high-margin revenues from ongoing sales of assays, reagents, and consumables, and sells through a combination of direct sales forces in developed markets and distributor partnerships in emerging regions.